CHIT1 and Gaucher disease: The increased circulating CHIT1 activity is a biomarker of lysosomal storage diseases such as Gaucher’s disease and is used to monitor progression or the efficacy of treatment with enzyme replacement therapy (Hollak et al. 1994).